Biotricity and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Biotricity and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
RedChip公司将在本周六晚7点（东部时间）在Bloomberg TV赞助的《Small Stocks, Big Money》节目上播出与Biotricity，Inc.（Nasdaq:BTCY）和bioAffinity Technologies，Inc.（Nasdaq:BIAF）的访谈。Bloomberg TV在美国大约有7300万户家庭可以收看。
Access the interviews in their entirety at:
Soligenix:
Biotricity:
bioAffinity Technologies:
Biotricity:
bioAffinity Technologies的总裁兼首席执行官Maria Zannes将在Bloomberg TV的RedChip节目上提供公司更新。bioAffinity Technologies是早期癌症诊断领域的新兴参与者。其旗舰产品CyPath Lung通过分析肺部微环境提高早期肺癌的检测效率。这种非侵入性的测试具有高灵敏度、特异性和准确性。肺癌往往在达到晚期时才被发现，治疗方案的效果不佳。早期检测可提高生存率并降低医疗费用。随着商业化计划的推广，包括德克萨斯州的试点计划和美国国防部为进行持续性研究而购买测试，公司已为创业板做好了准备。到2030年，肺癌筛查市场预计将达到57亿美元。公司正在开发由人工智能驱动的自动化数据分析来协助非侵入性诊断慢性阻塞性肺疾病和哮喘的细胞流式分析平台，这两种疾病的全球市场预计将在2027年达到82亿美元。公司拥有广泛的美国和国际专利。内部人士对公司的持股力度非常强，持股比例为39%并且持续增加。拥有高度经验的领导团队，bioAffinity Technologies在早期癌症诊断领域具备推动创新的优势。
In an exclusive interview, Dr. Waqaas Al-Siddiq, Founder and CEO of Biotricity, will share insight into the company's innovative portfolio of cardiac monitoring solutions, which includes the FDA-cleared Bioflux and Biocore devices, targeting a total addressable market of $35 billion. With its solutions utilized daily by cardiologists across 34 states and 500 centers, Biotricity has captured an 8% market share in cardiology, bolstered by high retention rates of approximately 99% and a recurring revenue base that boasts strong LTV-to-CAC ratios. Biotricity is on a clear path to profitability and expects to be EBITDA positive before the end of 2024.
在一次独家采访中，Biotricity的创始人兼CEO Dr. Waqaas Al-Siddiq将分享该公司创新的心脏监测解决方案组合的见解，其中包括FDA批准的Bioflux和Biocore设备，目标总市场价值达350亿美元。由34个州和500个中心的心脏病专家每天使用其解决方案，Biotricity在心脏病领域占据了8%的市场份额，支持率约为99%，并拥有一个循环收入基础，LTV-to-CAC比率强劲。Biotricity正在走向盈利，并预计在2024年底之前实现EBITDA盈利。
Maria Zannes, President and CEO of bioAffinity Technologies, appears on the RedChip Small Stocks, Big Money show on Bloomberg TV to provide a corporate update. bioAffinity Technologies is an emerging player in early-stage cancer diagnosis. Its flagship product, CyPath Lung, improves detection of early-stage lung cancer by analyzing the lung microenvironment. The noninvasive test has shown high sensitivity, specificity and accuracy. Lung cancer often goes undetected until it reaches late-stage when treatment options are less effective. Early detection increases survival and reduces medical costs. With commercialization underway, including a pilot program in Texas and the US DoD's purchase of tests for ongoing research, the Company is well-poised for growth. The lung cancer screening market is projected to reach $5.7 billion by 2030. The Company's flow cytometry platform, enhanced by AI-driven automated data analysis, is being developed to aid in noninvasive diagnosis of COPD and asthma, which have a combined global market expected to reach $8.2 billion by 2027. The Company holds extensive U.S. and international patents. Insiders show strong support for the Company with ownership at 39% and increasing. With a highly experienced leadership team, bioAffinity Technologies is well-positioned to drive innovation in early-stage cancer diagnosis.
Maria Zannes，bioAffinity Technologies的总裁兼CEO，出现在Bloomberg TV的RedChip Small Stocks，Big Money show上，提供公司更新。bioAffinity Technologies是早期癌症诊断的新兴参与者。旗舰产品CyPath Lung通过分析肺部微环境改善早期肺癌的检测。这种无创检测具有高灵敏度、特异性和准确性。肺癌通常在达到晚期时才能被检测出来，此时治疗选项不太有效。早期检测可以提高生存率并降低医疗费用。随着商业化逐步展开，包括德克萨斯州的试点计划和美国国防部为进行持续研究购买的测试，该公司发展前景良好。肺癌筛查市场预计到2030年将达到57亿美元。该公司的流式细胞术平台，辅以AI驱动的自动数据分析，正在开发用于非侵入性诊断COPD和哮喘的辅助诊疗工具，这两者的全球市场总价值预计将在2027年达到82亿美元。该公司拥有广泛的美国和国际专利。内部人士对该公司的支持较强，持股比例为39%，并在不断增长。凭借高度经验丰富的领导团队，bioAffinity Technologies有望在早期癌症诊断中推动创新。
About Biotricity
关于Biotricity
Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Physicians and patients trust Biotricity's unparalleled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit and follow us on Twitter and LinkedIn.
Biotricity正在通过实现遥测与慢性病管理之间的进一步连接，集中于心脏学领域，以此来改变保健市场。医生和病人都信任Biotricity的预防性护理和个人护理的卓越标准，包括针对慢性疾病的诊断和后诊断解决方案。该公司开发了全面的面向医疗和消费市场的远程健康监测解决方案。详情请访问，同样您也可以关注我们的 Twitter 和 LinkedIn。
About bioAffinity Technologies, Inc.
关于bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. The Company's first product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of bioAffinity Technologies. Research and optimization of the Company's platform technologies are conducted in its laboratories at Precision Pathology and The University of Texas at San Antonio. For more information, visit and follow us on LinkedIn, Facebook and X.
bioAffinity Technologies，Inc.致力于为早期癌症和肺部疾病以及广谱癌症治疗提供无创诊断。该公司的第一款产品CyPath Lung是一种无创检测方法，可以高灵敏度、特异性和准确性地检测早期肺癌。 CyPath Lung由bioAffinity Technologies子公司Precision Pathology实验室开发并作为实验室开发的检测方法（LDT）销售。该公司的平台技术研究和优化都在Precision Pathology和The University of Texas at San Antonio的实验室中进行。欲了解更多信息，请访问网站并在LinkedIn、Facebook和X上关注我们。
About RedChip Companies
关于RedChip公司
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
RedChip公司是一家国际投资关系、媒体和研究公司，专注于微型股和小型股公司。30多年来，RedChip为客户提供了具体的、可量化的结果。我们的每周在线报告《Small Stocks，Big Money》每周在线投资者共计60,000人。RedChip已经发展成为行业中最全面的服务平台，为微型库存和小型库存提供以下服务：为其股票调查提供遍布全球的分销网络；在美国主要城市进行零售和机构路演；对股票经纪人、RIA、机构和家族办公室进行出口推广；数字媒体投资者关系平台，已经产生了数百万独特的投资者浏览量；为投资者举办网络研讨会和小组电话；电视节目《Small Stocks, Big Money》每周在Bloomberg US播出，本地和全国市场的电视广告；公司和产品视频；网站设计；和传统的投资者关系服务，包括新闻稿撰写、投资者演示文稿开发、季度电话会议剧本撰写、战略咨询、筹资等。
To learn more about RedChip's products and services, please visit:
要了解更多有关RedChip的产品和服务的信息，请访问：
"Discovering Tomorrow's Blue Chips Today"
“发现明日的蓝筹股”
Follow RedChip on LinkedIn:
在LinkedIn上关注RedChip：
Follow RedChip on Facebook:
在Facebook上关注RedChip：
Follow RedChip on Instagram:
在Instagram上关注RedChip：
Follow RedChip on Twitter:
在Twitter上关注RedChip：
Follow RedChip on YouTube:
在YouTube上关注RedChip：
Follow RedChip on Rumble:
在Rumble上关注RedChip：
Subscribe to our Mailing List:
订阅我们的邮件列表：
Contact:
联系方式：
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com
SOURCE: RedChip
来源：RedChip